ClinConnect ClinConnect Logo
Search / Trial NCT06161662

Effect of Acupoint Stimulation on Postoperative Delirium and Electroencephalogram

Launched by ZHIHONG LU · Nov 30, 2023

Trial Information

Current as of June 08, 2025

Not yet recruiting

Keywords

Transcutaneous Electrical Acupoint Stimulation Postoperative Delirium Electroencephalogram

ClinConnect Summary

This clinical trial is studying the effects of a treatment called transcutaneous electrical acupoint stimulation (TEAS) on older patients who are having abdominal surgery. The goal is to see if TEAS can help reduce the chances of developing postoperative delirium (POD), which is confusion that can occur after surgery. The researchers will also look at changes in brain activity, measured by a test called an electroencephalogram (EEG), to understand how TEAS may help improve patients' mental clarity after surgery.

To participate in this trial, individuals must be 65 years or older and scheduled for elective abdominal surgery under general anesthesia. They should not have serious brain injuries, cognitive problems, or certain health issues that could interfere with the study. Participants will receive TEAS during their surgery and will be monitored for any changes in their condition afterward. This research could provide valuable insights into how TEAS may help improve recovery for older patients after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. aged 65 years or older
  • 2. American Society of Anesthesiologists (ASA) classification≤ Grade III
  • 3. Patients scheduled for elective abdominal surgery under general anesthesia
  • 4. Informed consent
  • Exclusion Criteria:
  • 1. Patients with severe central nervous system injury or severe cerebrovascular disease
  • 2. Patients with cognitive dysfunction assessed by Confusion Assessment Method before surgery
  • 3. Patients unable to cooperate with studies, such as psychiatric disorders or difficulty in communication
  • 4. Patients with severe hepatic and renal insufficiency
  • 5. Patients with severe respiratory diseases
  • 6. Patients with contraindication for transcutaneous electrical stimulation, such as implanted electrophysiological devices, skin infection and damage at acupuncture points
  • 7. Anticipated duration of anesthesia shorter than 2 hours or postoperative hospital stay shorter than 3 days

About Zhihong Lu

Zhihong Lu is a dedicated clinical trial sponsor with a focus on advancing innovative therapies and treatments across various medical fields. Committed to rigorous scientific standards and ethical practices, Zhihong Lu leads research initiatives aimed at improving patient outcomes and enhancing healthcare delivery. With a collaborative approach, the organization partners with leading researchers and institutions to conduct high-quality clinical trials that contribute to the body of medical knowledge and address unmet clinical needs. Through meticulous oversight and a commitment to excellence, Zhihong Lu strives to bring revolutionary medical advancements from the laboratory to the patient bedside.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported